Dolutegravir Sodium
ATC J05AX12 · 3 markets · 16 records
FR 6 records · 3 shown of 3
Only this ingredient
- 5 mgtabletTIVICAY 5 mg, comprimé dispersible
- 52.6 mgtabletTIVICAY 10 mg, comprimé pelliculé
Combination products containing this ingredient
- 52.6 mgtablet CombinationAbacavir Sulfate 702 mg + Dolutegravir Sodium 52.6 mg + Lamivudine 300 mgTRIUMEQ 50 mg/600 mg/300 mg, comprimé pelliculé
3 records · 0 manufacturers 3 registros · 0 fabricantes 3 个记录 · 0 个厂家 3 個記錄 · 0 個廠商
With a brand name Con nombre comercial 有商品名 有商品名DOVATO 50 mg/300 mg, comprimé pelliculé ×1JULUCA 50 mg/25 mg, comprimé pelliculé ×1TRIUMEQ 5 mg/60 mg/30 mg, comprimé dispersible ×1
Full list in the data package Lista completa en el paquete de datos 完整清单见数据包 完整清單見資料包
AU 4 records · 4 shown of 4
Only this ingredient
- 26.3 mgtabletTIVICAY dolutegravir (as sodium) 50 mg film-coated tablet bottle
- 10.5 mgtabletTIVICAY dolutegravir (as sodium) 50 mg film-coated tablet bottle
- 5.26 mgtabletTIVICAY PD dolutegravir (as sodium) 5 mg dispersible tablet bottle
Combination products containing this ingredient
- 52.6 mgtablet CombinationDolutegravir Sodium 52.6 mg + Lamivudine 300 mgDOVATO 50/300 dolutegravir (as sodium) 50 mg/lamivudine 300 mg tablet bottle
SG 4 records · 4 shown of 4
The same ingredient can carry completely different
brand names in different countries, and the same name can point to a different ingredient.
Listed by country — not interchangeable.
Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.
A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.